upcoming glp-1 drugs Costs Explained: Managing Coverage Challenges Until now, they were largely
Description
There has also been a lot of discussion on whether the benefits last after stopping taking these drugs, especially if no diet or lifestyle changes are made while on them
GLP-1RAs can also enhance glycolytic and oxidative pathways via AMPK activation, thereby limiting ectopic lipid accumulation and lipotoxic stress [55, 56]

FDA-approved GLP-1s arent designed to be split into tiny doses, so people turn to compounded versions

doi:10.2165/00003088-199324050-00007 222

With more and more people taking GLP-1 agonists, these adverse reactions are presenting supplement manufacturers with a special opportunity to serve a burgeoning market
Hydrate: even mild dehydration makes fatigue worse
